Journey Medical Corporation
DERM
$7.42
$0.020.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 14.23% | 4.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.23% | -3.53% | |||
| Cost of Revenue | 3.11% | 114.13% | |||
| Gross Profit | 20.61% | -26.65% | |||
| SG&A Expenses | 12.42% | 5.06% | |||
| Depreciation & Amortization | -0.09% | -68.90% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.64% | 44.59% | |||
| Operating Income | 13.48% | -248.79% | |||
| Income Before Tax | 8.27% | -357.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.80% | -367.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.80% | -367.78% | |||
| EBIT | 13.48% | -248.79% | |||
| EBITDA | 19.79% | -170.26% | |||
| EPS Basic | 9.49% | -352.24% | |||
| Normalized Basic EPS | 10.92% | -342.67% | |||
| EPS Diluted | 9.49% | -366.81% | |||
| Normalized Diluted EPS | 10.92% | -342.67% | |||
| Average Basic Shares Outstanding | 3.01% | 6.10% | |||
| Average Diluted Shares Outstanding | 3.01% | 6.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||